Skip to main content
All Posts By

Andy

Building a Life Sciences Innovation District in Prince William County on BioTalk

By BioTalk with Rich Bendis Podcast, News

This episode of the BioTalk with Rich Bendis Podcast brings together leaders from industry, academia, and economic development to unpack the vision behind a new life sciences Innovation District anchored in Prince William County. With introductions to NAUGEN, George Mason University’s Institute for Biohealth Innovation, and the Prince William County Department of Economic Development, setting the stage for how each organization contributes to the district’s foundation. The guests discuss the life science assets, research strengths, and translational capabilities that define the district and explain why it is well-positioned to support biotechnology and advanced R&D companies.

The podcast explores how the partnership between Prince William County, George Mason University, and the City of Manassas came together, outlining the distinct roles each plays in advancing a shared strategy. The episode also introduces the NISA program, detailing how it supports companies seeking a soft-landing pathway into the district, the types of organizations best suited for the program, and the facilities, talent, and collaborative resources participants can access both immediately and over time.

Listen now via your favorite podcast platform:
Apple: https://apple.co/4p94Dqe
Spotify: https://bit.ly/3Y7dJZw
iHeart Podcasts: https://ihr.fm/3KLV7v4
Amazon Music Podcasts: https://amzn.to/4pajS1P
YouTube Music Podcasts: https://bit.ly/4phRV8I
TuneIn: https://bit.ly/44GoG7Y

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Jaehan Park is Founder and CEO of NAUGEN, a global innovation accelerator advancing novel technologies across life sciences and deep tech. With more than 25 years of experience in strategy and business development, he has led collaborations spanning cancer immunotherapy, vaccines, and biologics with global pharmaceutical companies and academic institutions. He leads the NISA Program in partnership with George Mason University and serves as a Mentor-in-Residence at KIC DC, supporting international startups entering U.S. markets.

Amy Adams is Executive Director of George Mason University’s Institute for Biohealth Innovation, where she advances biohealth research and innovation across more than 300 faculty and thousands of students. Her work focuses on partnerships, shared research infrastructure, and building hubs that connect academia with industry. She is co-leading the development of the Innovation District anchored at Mason’s SciTech campus and serves on the boards of BioHealth Innovation and the Association of University Research Parks.

Christina Winn leads the Prince William County Department of Economic Development, guiding investment, business growth, and redevelopment efforts across one of Virginia’s largest counties. She is overseeing the development of a research-driven Innovation District in partnership with George Mason University and the City of Manassas, supported by a GO Virginia grant. Her career includes leading large-scale economic development initiatives that have driven significant capital investment, job creation, and national visibility for the region.

Entrepreneurs in Residence Call: Biohealth Commercialization Leaders with AI and Quantum Experience

By News

BioHealth Innovation is expanding its Entrepreneurs in Residence (EIR) network and is seeking experienced leaders at the intersection of biohealth and advanced technologies, including artificial intelligence and quantum computing.

This call is for seasoned operators with a strong commercialization background. Ideal candidates have taken innovations from concept through market entry, licensing, spinout, or acquisition, and understand the realities of regulatory pathways, customer discovery, fundraising, and scale. Experience working with startups, academic technologies, government labs, or early-stage venture-backed companies is essential. EIRs serve in a part time advisory role with BHI, working flexibly alongside other professional commitments while contributing hands on commercialization expertise.

We are particularly interested in EIRs who can translate AI and quantum capabilities into practical biohealth applications, including drug discovery, diagnostics, clinical research, manufacturing, data analytics, and health system innovation. The role requires comfort working across technical, business, and stakeholder environments.

EIRs work closely with entrepreneurs, researchers, and partners across the BioHealth Capital Region and nationally. Engagements may include advising project teams, supporting partner initiatives, guiding commercialization strategy, and mentoring founders navigating early growth decisions.

This is an opportunity to contribute deep expertise to high-potential biohealth innovations while remaining connected to a collaborative, mission-driven ecosystem.

Interested candidates should contact BHI Founder, President, and CEO, Rich Bendis at rbendis@biohealthinnovation.org, with a summary of their background, commercialization experience, and areas of technical focus.

 

BHI EIR Insights: 7 Tactics to Optimize Launch Messaging – Part I

By EIR Insights, News

by Jonathan Kay, MPP, Managing Partner, Health Market Experts & BioHealth Innovation, Inc. Entrepreneur-in-Residence

Healthcare is complicated. Communicating effectively doesn’t need to be.

For a new medical technology, biologic, pharmaceutical, or digital health solution, a critical element of go-to-market strategy (GTM) and initial commercial success is messaging.

But messaging often doesn’t get the attention it deserves.

GTM messaging could include messages to any: physicians, hospital administrators, policy makers, patients, caregivers, payers, and more.

This post kicks off our 7-part series on Optimizing Launch Messaging 🚀, where we will share 7 valuable tactics to help achieve your goals related to access, commercial success, and improved patient outcomes.

Tactic 1: Test, Don’t Guess

The first step to optimizing launch strategy is embracing a data-driven mindset:

Healthcare markets are complex in so many ways. Think of the scientific, clinical, regulatory, reimbursement, and competitive landscape. Testing in a complex and changing environment helps minimize risk and maximize potential.

Companies run clinical trials to test the impact of a therapy. Similarly, commercial teams should test their launch communications to ensure they are effective and safe. That is, are the messages clear, credible, and persuasive? Do the messages avoid unintended consequences?

Why test messages? We test messages to:

  • Understand unmet needs
  • Assess competitive differentiators
  • Understand which messages resonate and why
  • Learn how to motivate appropriate behavior

Do you have a positive example from when you tested messages in advance of using them? Share your thoughts below!

At Health Market Experts, we make corporate and brand messaging more efficient and effective. If your organization is preparing to launch a product or a campaign, connect with us to learn more about how we can help you develop and execute your launch plan and maximize success. Ask us about message awareness and attribution, too.

This post was written with NI not AI (written by a human using natural intelligence).

This post expands on content I previously wrote as a blog at Catalant and delivered in guest lectures at Rutgers Business School.

Visit https://www.linkedin.com/in/jonathan-kay-healthcare/ to connect with Jon on LinkedIn.

Strengthening Virginia’s BioHealth Future with Secretary of Commerce and Trade Juan Pablo Segura on BioTalk

By BioTalk with Rich Bendis Podcast, News

Secretary Juan Pablo Segura joins BioTalk for a conversation about Virginia’s growing position in the biohealth economy and the statewide strategy behind it. He outlines the significance of the new partnership with AstraZeneca, Lilly, and Merck, including up to $120 million in private investment to create a workforce development center and expand the Commonwealth’s life sciences capacity. Segura talks through how Virginia approaches company recruitment, what investors are responding to, and why the state is seeing increased interest from biomanufacturing and advanced R&D companies. He also discusses Virginia’s use of public-private partnerships to accelerate industry growth, strengthen the talent pipeline, and support emerging hubs across the Commonwealth. The conversation closes with a look at Virginia’s role in the BioHealth Capital Region and how the regional identity helps amplify the state’s message as it continues building a competitive biohealth ecosystem.

Listen now on your favorite podcast platform:
Apple: https://apple.co/3M2UNbB
Spotify: https://bit.ly/4izRPYa
iHeart Podcasts: https://ihr.fm/3Ktc0u5
Amazon Podcasts: https://amzn.to/3K5kkjN
YouTube Music Podcasts: https://bit.ly/4owIZfc
TuneIn: https://bit.ly/4ptw26O


Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Juan Pablo Segura is the Secretary of Commerce and Trade for the Commonwealth of Virginia. He leads 13 agencies focused on economic growth, business development, and industry expansion across the state. Before entering public service, Segura spent his career building companies in the digital health sector, most notably as a founder of Babyscripts, a widely adopted maternity care platform. His work has been recognized by Startup Health, CTIA, EY, and the White House. He is a CPA and a graduate of the University of Notre Dame, and he lives in Henrico, Virginia with his family.

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.